Biosynth Life Sciences India Limited, a active public limited company, was established on 13 April 2006 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24234TN2006PLC059506. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Srinivasan Ranganathan (Director), Ganesan Anandanarayanan (Director), Venkateswaran Natarajan (Director). Past directors included Srinivasan Gopinath, Srinivasan Ranganathan, Raghupathy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dhun Building No.827, Anna Salai, Chennai, Tamil Nadu, 600002.
U24234TN2006PLC059506
059506
13 April 2006
₹1.00 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Biosynth Life Sciences India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasan Ranganathan | Director | 23 Jan 2012 | Current |
| Ganesan Anandanarayanan | Director | 15 Feb 2024 | Current |
| Venkateswaran Natarajan | Director | 06 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Director | 21 Oct 2011 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biosynth Life Sciences India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 110.34% decrease in profit. The company's net worth dipped by a decrease of 2.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Biosynth Life Sciences India had a promoter holding of 15.00% and a public holding of 85.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Biosynth Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biosynth Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosynth Life Sciences India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Biosynth Life Sciences India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Biosynth Life Sciences India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
Progress on Ganesan Anandanarayanan was appointed as a Director was appointed as a Director on 15 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
The activity Venkateswaran Natarajan was appointed as a Director was appointed as a Director on 06 Feb 2014 & has been associated with this company since 11 years 9 months . was completed.
Progress on Srinivasan Ranganathan was appointed as a Director was appointed as a Director on 23 Jan 2012 & has been associated with this company since 13 years 10 months . was documented.
Progress on Biosynth Life Sciences India Limited was registered on 13 Apr 2006 with Roc Chennai & aged 19 years 7 months as per MCA records. was documented.
The CIN of Biosynth Life Sciences India Limited is U24234TN2006PLC059506.
Biosynth Life Sciences India Limited is headquartered at Dhun Building No.827, Anna Salai, Chennai, Tamil Nadu, 600002.
Biosynth Life Sciences India Limited was incorporated on 13 April 2006.
The current directors of Biosynth Life Sciences India Limited are
The primary industry of Biosynth Life Sciences India Limited is Pharma.
Biosynth Life Sciences India Limited is unlisted.
The authorized capital of Biosynth Life Sciences India Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Biosynth Life Sciences India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX